Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer

Current Cancer Drug Targets

Volumn 7, Issue 7, 2007, Pages 613-622

  Chen, Zhuo ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; HLA ANTIGEN; KERATIN; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MOESIN; MYC PROTEIN; PHOSPHOLIPASE C GAMMA1; PROTEIN BCL 2; PROTEIN CDC42; PROTEIN P53; RAC PROTEIN; RETINOBLASTOMA PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; STAT1 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNINDEXED DRUG; UVOMORULIN;

CANCER INVASION; CANCER RESEARCH; CANCER SURVIVAL; CELL ADHESION; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PROGNOSIS; PROTEIN TARGETING; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 35948936019     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907782418301     Document Type: Review

References (152)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
2. Jemal, A.; Murray, T.; Ward, E.; Samuels, A.; Tiwari, R. C.; Ghafoor, A.; Feuer, E. J.; Thun, M. J. Cancer statistics, 2005. CA Cancer J. Clin. 2005, 55, 10-30.
3. Cancer fact & figures 2005. Eds. American Cancer Society 2005, 17.
4. Som, P. M. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am. J. Roentgenol. 1992, 158, 961-969.
5. Leemans, C. R.; Tiwari, R.; Nauta, J. J.; van der Waal, I.; Snow, G. B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993, 71, 452-456.
6. Jones, A. S.; Roland, N. J.; Field, J. K.; Phillips, D. E. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin. Otolaryngol. Allied Sci. 1994, 19, 63-69.
7. Johnson, J. T.; Barnes, E. L.; Myers, E. N.; Schramm, V. L. Jr.; Borochovitz, D.; Sigler, B. A. The extracapsular spread of tumors in cervical node metastasis. Arch. Otolaryngol. 1981, 107, 725-729.
8. Woolgar, J. A. Pathology of the N0 neck. Br. J. Oral Maxillofac. Surg. 1999, 37, 205-209.
9. Jones, A. S.; Phillips, D. E.; Helliwell, T. R.; Roland, N. J. Occult node metastases in head and neck squamous carcinoma. Eur. Arch. Otorhinolaryngol. 1993, 250, 446-449.
10. van Wilgen, C. P.; Dijkstra, P. U.; van der Laan, B. F.; Plukker, J. T.; Roodenburg, J. L. Shoulder complaints after nerve sparing neck dissections. Int. J. Oral Maxillofac. Surg. 2004, 33, 253-257.
11. van Wilgen, C. P.; Dijkstra, P. U.; Nauta, J. M.; Vermey, A.; Roodenburg, J. L. Shoulder pain and disability in daily life, following supraomohyoid neck dissection: a pilot study. J. Craniomaxillofac. Surg. 2003, 31, 183-186.
12. Shah, J. P. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am. J. Surg. 1990, 160, 405-409.
13. Kramer, D.; Durham, J. S.; Jackson, S.; Brookes, J. Management of the neck in N0 squamous cell carcinoma of the oral cavity. J. Otolaryngol. 2001, 30, 283-288.
14. Chambers, A. F.; Groom, A. C.; MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2, 563-572.
15. Fidler, I. J. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg. Oncol. Clin. N. Am. 2001, 10, 257-269, vii-viiii.
16. Fidler, I. J. The organ microenvironment and cancer metastasis. Differentiation 2002, 70, 498-505.
17. Fidler, I. J. Critical determinants of metastasis. Semin. Cancer Biol. 2002, 12, 89-96.
18. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3, 453-458.
19. Chin, D.; Boyle, G. M.; Kane, A. J.; Theile, D. R.; Hayward, N. K.; Parson, P. G.; Coman, W. B. Invasion and metastasis markers in cancers. Br. J. Plast. Surg. 2005, 58, 466-474.
20. Rodrigo, J. P.; Suarez, C.; Ferlito, A.; Devaney, K. O.; Petruzzelli, G. J.; Rinaldo, A. Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma. Acta. Otolaryngol. 2003, 123, 100-105.
21. Zender, C. A.; Petruzzelli, G. J. Why do patients with head and neck squamous cell carcinoma experience distant metastases: can they be prevented? Curr. Opin. Otolaryngol. Head Neck Surg. 2005, 13, 101-104.
22. Howell, G. M.; Grandis, J. R. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 2005, 27, 710-717.
23. Kramer, R. H.; Shen, X.; Zhou, H. Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev. 2005, 24, 35-45.
24. Choi, P.; Chen, C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005, 104, 1113-1128.
25. Ramaswamy, S.; Ross, K. N.; Lander, E. S.; Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33, 49-54.
26. Fidler, I. J.; Kripke, M. L. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat. Genet. 2003, 34, 23; author reply 25.
27. Roepman, P.; Wessels, L. F.; Kettelarij, N.; Kemmeren, P.; Miles, A. J.; Lijnzaad, P.; Tilanus, M. G.; Koole, R.; Hordijk, G. J.; van der Vliet, P. C.; Reinders, M. J.; Slootweg, P. J.; Holstege, F. C. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat. Genet. 2005, 37, 182-186.
28. Roepman, P.; Kemmeren, P.; Wessels, L. F.; Slootweg, P. J.; Holstege, F. C. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res. 2006, 66, 2361-2366.
29. Chung, C. H.; Parker, J. S.; Karaca, G.; Wu, J.; Funkhouser, W. K.; Moore, D.; Butterfoss, D.; Xiang, D.; Zanation, A.; Yin, X.; Shockley, W. W.; Weissler, M. C.; Dressler, L. G.; Shores, C. G.; Yarbrough, W. G.; Perou, C. M. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004, 5, 489-500.
30. Jeon, G. A.; Lee, J. S.; Patel, V.; Gutkind, J. S.; Thorgeirsson, S. S.; Kim, E. C.; Chu, I. S.; Amornphimoltham, P.; Park, M. H. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int. J. Cancer 2004, 112, 249-258.
31. O'Donnell, R. K.; Kupferman, M.; Wei, S. J.; Singhal, S.; Weber, R.; O'Malley, B.; Cheng, Y.; Putt, M.; Feldman, M.; Ziober, B.; Muschel, R. J. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005, 24, 1244-1251.
32. Ferris, R. L.; Xi, L.; Raja, S.; Hunt, J. L.; Wang, J.; Gooding, W. E.; Kelly, L.; Ching, J.; Luketich, J. D.; Godfrey, T. E. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res. 2005, 65, 2147-2156.
33. Schmalbach, C. E.; Chepeha, D. B.; Giordano, T. J.; Rubin, M. A.; Teknos, T. N.; Bradford, C. R.; Wolf, G. T.; Kuick, R.; Misek, D. E.; Trask, D. K.; Hanash, S. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2004, 130, 295-302.
34. Sok, J. C.; Kuriakose, M. A.; Mahajan, V. B.; Pearlman, A. N.; DeLacure, M. D.; Chen, F. A. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch. Otolaryngol. Head Neck Surg. 2003, 129, 760-770.
35. Warner, G. C.; Reis, P. P.; Jurisica, I.; Sultan, M.; Arora, S.; Macmillan, C.; Makitie, A. A.; Grenman, R.; Reid, N.; Sukhai, M.; Freeman, J.; Gullane, P.; Irish, J.; Kamel-Reid, S. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int. J. Cancer 2004, 110, 857-868.
36. Belbin, T. J.; Singh, B.; Smith, R. V.; Socci, N. D.; Wreesmann, V. B.; Sanchez-Carbayo, M.; Masterson, J.; Patel, S.; Cordon-Cardo, C.; Prystowsky, M. B.; Childs, G. Molecular profiling of tumor progression in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 2005, 131, 10-18.
37. Nagata, M.; Fujita, H.; Ida, H.; Hoshina, H.; Inoue, T.; Seki, Y.; Ohnishi, M.; Ohyama, T.; Shingaki, S.; Kaji, M.; Saku, T.; Takagi, R. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int. J. Cancer 2003,106, 683-689.
38. Zhang, X.; Liu, Y.; Gilcrease, M. Z.; Yuan, X. H.; Clayman, G. L.; Adler-Storthz, K.; Chen, Z. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002, 95, 1663-1672.
39. Chen, Z.; Zhang, K.; Zhang, X.; Yuan, X. H.; Yuan, Z.; Jin, L.; Xiong, M. Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma. Clin. Exp. Metastasis 2003, 20, 335-342.
40. Zhang, X.; Hunt, J. L.; Landsittel, D. P.; Muller, S.; Adler-Storthz, K.; Ferris, R. L.; Shin, D. M.; Chen, Z. G. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin. Cancer Res. 2004, 10, 8451-8459.
41. Wang, J.; Zhang, X.; Thomas, S. M.; Grandis, J. R.; Wells, A.; Chen, Z. G.; Ferris, R. L. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 2005, 24, 5897-5904.
42. Wang, J.; Xi, L.; Hunt, J. L.; Gooding, W.; Whiteside, T. L.; Chen, Z.; Godfrey, T. E.; Ferris, R. L. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 2004, 64, 1861-1866.
43. Zhang, X.; Hunt, J. L.; Shin, D. M.; Chen, Z. G. Down Regulation of S100A2 in Lymph Node Metastases of the Head and Neck Cancer. Head Neck 2007, 29(3), 236-243.
44. Abraham, M. T.; Kuriakose, M. A.; Sacks, P. G.; Yee, H.; Chiriboga, L.; Bearer, E. L.; Delacure, M. D. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001, 111, 1285-1289.
45. Salesiotis, A. N.; Cullen, K. J. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr. Opin. Oncol. 2000, 12, 229-239.
46. Thomas, G. R.; Nadiminti, H.; Regalado, J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int. J. Exp. Pathol. 2005, 86, 347-363.
47. Wu, W.; Tang, X.; Hu, W.; Lotan, R.; Hong, W. K.; Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis 2002, 19, 319-326.
48. Takes, R. P.; Baatenburg De Jong, R. J.; Alles, M. J.; Meeuwis, C. A.; Marres, H. A.; Knegt, P. P.; De La Riviere, G. B.; De Wilde, P. C.; Mooi, W. J.; Hermans, J.; Van Krieken, J. H. Markers for nodal metastasis in head and neck squamous cell cancer. Arch. Otolaryngol. Head Neck Surg. 2002, 128, 512-518.
49. Takes, R. P.; Baatenburg de Jong, R. J.; Wijffels, K.; Schuuring, E.; Litvinov, S. V.; Hermans, J.; van Krieken, J. H. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. J. Pathol. 2001, 194, 298-302.
50. Sheikh, H.; Murphy, J.; Hunt, J. L. NM-23 gene loss of heterozygosity and protein expression in high-stage laryngeal squamous cell carcinomas. Diagn. Mol. Pathol. 2006, 15, 1-6.
51. Spafford, M. F.; Koeppe, J.; Pan, Z.; Archer, P. G.; Meyers, A. D.; Franklin, W. A.; Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 1996, 122, 627-632.
52. Katayama, A.; Bandoh, N.; Kishibe, K.; Takahara, M.; Ogino, T.; Nonaka, S.; Harabuchi, Y. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin. Cancer Res. 2004, 10, 634-640.
53. Colognato, H.; Yurchenco, P. D. Form and function: the laminin family of heterotrimers. Dev. Dyn. 2000, 218, 213-234.
54. Pyke, C.; Salo, S.; Ralfkiaer, E.; Romer, J.; Dano, K.; Tryggvason, K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995, 55, 4132-4139.
55. Zhang, K.; Kramer, R. H. Laminin 5 deposition promotes keratinocyte motility. Exp. Cell Res. 1996, 227, 309-322.
56. Ginos, M. A.; Page, G. P.; Michalowicz, B. S.; Patel, K. J.; Volker, S. E.; Pambuccian, S. E.; Ondrey, F. G.; Adams, G. L.; Gaffney, P. M. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004, 64, 55-63.
57. Patarroyo, M.; Tryggvason, K.; Virtanen, I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 2002, 12, 197-207.
58. Patel, V.; Aldridge, K.; Ensley, J. F.; Odell, E.; Boyd, A.; Jones, J.; Gutkind, J. S.; Yeudall, W.A. Laminin-gamma2 overexpression in head-and-neck squamous cell carcinoma. Int. J. Cancer 2002, 99, 583-588.
59. Niki, T.; Kohno, T.; Iba, S.; Moriya, Y.; Takahashi, Y.; Saito, M.; Maeshima, A.; Yamada, T.; Matsuno, Y.; Fukayama, M.; Yokota, J.; Hirohashi, S. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol. 2002, 160, 1129-1141.
60. Kosmehl, H.; Berndt, A.; Strassburger, S.; Borsi, L.; Rousselle, P.; Mandel, U.; Hyckel, P.; Zardi, L.; Katenkamp, D. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br. J. Cancer 1999, 81, 1071-1079.
61. Swisshelm, K.; Macek, R.; Kubbies, M. Role of claudins in tumorigenesis. Adv. Drug Deliv. Rev. 2005, 57, 919-928.
62. Sawada, N.; Murata, M.; Kikuchi, K.; Osanai, M.; Tobioka, H.; Kojima, T.; Chiba, H. Tight junctions and human diseases. Med. Electron Microsc. 2003, 36, 147-156.
63. Baker, S. E.; Hopkinson, S. B.; Fitchmun, M.; Andreason, G. L.; Frasier, F.; Plopper, G.; Quaranta, V.; Jones, J. C. Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. J. Cell Sci. 1996, 109(Pt 10), 2509-2520.
64. Mizushima, H.; Takamura, H.; Miyagi, Y.; Kikkawa, Y.; Yamanaka, N.; Yasumitsu, H.; Misugi, K.; Miyazaki, K. Identification of integrin-dependent and -independent cell adhesion domains in COOH-terminal globular region of laminin-5 alpha 3 chain. Cell Growth Differ. 1997, 8, 979-987.
65. Ramos, D. M.; But, M.; Regezi, J.; Schmidt, B. L.; Atakilit, A.; Dang, D.; Ellis, D.; Jordan, R.; Li, X. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol. 2002, 21, 297-307.
66. Li, X.; Yang, Y.; Hu, Y.; Dang, D.; Regezi, J.; Schmidt, B. L.; Atakilit, A.; Chen, B.; Ellis, D.; Ramos, D. M. Alphavbeta6-Fyn signaling promotes oral cancer progression. J. Biol. Chem. 2003, 278, 41646-41653.
67. Jones, J.; Watt, F. M.; Speight, P. M. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J. Oral Pathol. Med. 1997, 26, 63-68.
68. Dang, D.; Yang, Y.; Li, X.; Atakilit, A.; Regezi, J.; Eisele, D.; Ellis, D.; Ramos, D. M. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix. Biochem. Biophys. Res. Commun. 2004, 316, 937-942.
69. Carter, W. G.; Ryan, M. C.; Gahr, P. J. Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 1991, 65, 599-610.
70. DiPersio, C. M.; Hodivala-Dilke, K. M.; Jaenisch, R.; Kreidberg, J. A.; Hynes, R. O. Alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. J. Cell Biol. 1997, 137, 729-742.
71. Gonzales, M.; Haan, K.; Baker, S. E.; Fitchmun, M.; Todorov, I.; Weitzman, S.; Jones, J. C. A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation. Mol. Biol. Cell 1999, 10, 259-270.
72. Manohar, A.; Shome, S.G.; Lamar, J.; Stirling, L.; Iyer, V.; Pumiglia, K.; DiPersio, C.M. Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway. J. Cell Sci. 2004, 117, 4043-4054.
73. Goldfinger, L. E.; Hopkinson, S. B.; deHart, G. W.; Collawn, S.; Couchman, J. R.; Jones, J. C. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 1999, 112(Pt 16), 2615-2629.
74. Mercurio, A. M.; Rabinovitz, I.; Shaw, L. M. The alpha 6 beta 4 integrin and epithelial cell migration. Curr. Opin. Cell Biol. 2001, 13, 541-545.
75. Rabinovitz, I.; Mercurio, A. M. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J. Cell Biol. 1997, 139, 1873-1884.
76. Shintani, S.; Li, C.; Mihara, M.; Nakashiro, K.; Hamakawa, H. Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett. 2003, 201, 149-155.
77. Wilhelmsen, K.; Litjens, S. H.; Sonnenberg, A. Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. Mol. Cell Biol. 2006, 26, 2877-2886.
78. Janes, S. M.; Watt, F. M. New roles for integrins in squamous-cell carcinoma. Nat. Rev. Cancer 2006, 6, 175-183.
79. Tucker, G. C. Alpha v integrin inhibitors and cancer therapy. Curr. Opin. Investig. Drugs 2003, 4, 722-731.
80. Tucker, G. C. Integrins: molecular targets in cancer therapy. Curr. Oncol. Rep. 2006, 8, 96-103.
81. Eble, J. A.; Haier, J. Integrins in cancer treatment. Curr. Cancer Drug Targets 2006, 6, 89-105.
82. Fernandes, D. J.; Bonacci, J. V.; Stewart, A. G. Extracellular matrix, integrins, and mesenchymal cell function in the airways. Curr. Drug Targets 2006, 7, 567-577.
83. Akervall, J. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev. 2005, 24, 87-94.
84. Akervall, J.; Guo, X.; Qian, C. N.; Schoumans, J.; Leeser, B.; Kort, E.; Cole, A.; Resau, J.; Bradford, C.; Carey, T.; Wennerberg, J.; Anderson, H.; Tennvall, J.; Teh, B. T. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin. Cancer Res. 2004, 10, 8204-8213.
85. Bankfalvi, A.; Krassort, M.; Buchwalow, I. B.; Vegh, A.; Felszeghy, E.; Piffko, J. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J. Pathol. 2002, 198, 343-351.
86. Piffko, J.; Bankfalvi, A.; Klauke, K.; Dreier, R.; Joos, U.; Bocker, W.; Schmid, K. W. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J. Oral Pathol. Med. 1996, 25, 502-506.
87. Kawano, T.; Nakamura, Y.; Yanoma, S.; Kubota, A.; Furukawa, M.; Miyagi, Y.; Tsukuda, M. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris. Nasus. Larynx 2004, 31, 35-41.
88. Kunishi, M.; Kayada, Y.; Yoshiga, K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int. J. Oral Maxillofac. Surg. 1997, 26, 280-283.
89. Oliveira, D. T.; Sherriff, M.; Odell, E. W. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J. Oral Pathol. Med. 1998, 27, 303-307.
90. Sato, S.; Miyauchi, M.; Takekoshi, T.; Zhao, M.; Kudo, Y.; Ogawa, I.; Kitagawa, S.; Fujita, M.; Takata, T. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol. 2000, 36, 545-549.
91. Curran, S.; Murray, G. I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 1999, 189, 300-308.
92. Stetler-Stevenson, W. G.; Aznavoorian, S.; Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 1993, 9, 541-573.
93. Kawata, R.; Shimada, T.; Maruyama, S.; Hisa, Y.; Takenaka, H.; Murakami, Y. Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis. Acta Otolaryngol. 2002, 122, 101-106.
94. Kurahara, S.; Shinohara, M.; Ikebe, T.; Nakamura, S.; Beppu, M.; Hiraki, A.; Takeuchi, H.; Shirasuna, K. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999, 21, 627-638.
95. P, O. C.; Rhys-Evans, P. H.; Eccles, S. A. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 2001, 127, 813-820.
96. Hong, S. D.; Hong, S. P.; Lee, J. I.; Lim, C. Y. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol. 2000, 36, 207-213.
97. Imanishi, Y.; Fujii, M.; Tokumaru, Y.; Tomita, T.; Kanke, M.; Kanzaki, J.; Kameyama, K.; Otani, Y.; Sato, H. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum. Pathol. 2000, 31, 895-904.
98. Nozaki, S.; Endo, Y.; Nakahara, H.; Yoshizawa, K.; Hashiba, Y.; Kawashiri, S.; Tanaka, A.; Nakagawa, K.; Matsuoka, Y.; Kogo, M.; Yamamoto, E. Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor. Oral Oncol. 2005, 41, 971-977.
99. Aguirre-Ghiso, J. A.; Estrada, Y.; Liu, D.; Ossowski, L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res. 2003, 63, 1684-1695.
100. Schmidt, M.; Hoppe, F. Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients. Acta Otolaryngol. 1999, 119, 949-953.
101. Yoshizaki, T.; Maruyama, Y.; Sato, H.; Furukawa, M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer 2001, 95, 44-50.
102. Gohji, K.; Fujimoto, N.; Ohkawa, J.; Fujii, A.; Nakajima, M. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer. Br. J. Cancer 1998, 77, 650-655.
103. Kanayama, H.; Yokota, K.; Kurokawa, Y.; Murakami, Y.; Nishitani, M.; Kagawa, S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 1998, 82, 1359-1366.
104. Visscher, D. W.; Hoyhtya, M.; Ottosen, S. K.; Liang, C. M.; Sarkar, F. H.; Crissman, J. D.; Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 1994, 59, 339-344.
105. Kikuchi, R.; Noguchi, T.; Takeno, S.; Kubo, N.; Uchida, Y. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br. J. Cancer 2000, 83, 215-218.
106. Overall, C. M.; Kleifeld, O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. British J. Cancer 2006, 94, 941-946.
107. Overall, C. M.; Kleifeld, O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 2006, 6, 227-239.
108. Shook, D.; Keller, R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 2003, 120, 1351-1383.
109. Thiery, J. P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15, 740-746.
110. Lee, J. M.; Dedhar, S.; Kalluri, R.; Thompson, E. W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172, 973-981.
111. Thompson, E. W.; Newgreen, D. F.; Tarin, D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005, 65, 5991-5995.
112. Tarin, D.; Thompson, E. W.; Newgreen, D. F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005, 65, 5996-6000.
113. Rodrigo, J. P.; Ferlito, A.; Suarez, C.; Shaha, A. R.; Silver, C. E.; Devaney, K. O.; Bradley, P. J.; Bocker, J. M.; McLaren, K. M.; Grenman, R.; Rinaldo, A. New molecular diagnostic methods in head and neck cancer. Head Neck 2005, 27, 995-1003.
114. Tanaka, N.; Odajima, T.; Ogi, K.; Ikeda, T.; Satoh, M. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br. J. Cancer 2003, 89, 557-563.
115. Chow, V.; Yuen, A. P.; Lam, K. Y.; Tsao, G. S.; Ho, W. K.; Wei, W. I. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J. Cancer Res. Clin. Oncol. 2001, 127, 59-63.
116. Shinohara, M.; Hiraki, A.; Ikebe, T.; Nakamura, S.; Kurahara, S.; Shirasuna, K.; Garrod, D. R. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J. Pathol. 1998, 184, 369-381.
117. Rodrigo, J. P.; Dominguez, F.; Alvarez, C.; Manrique, C.; Herrero, A.; Suarez, C. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur. J. Cancer 2002, 38, 1059-1064.
118. Bankfalvi, A.; Krassort, M.; Vegh, A.; Felszeghy, E.; Piffko, J. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J. Oral. Pathol. Med. 2002, 31, 450-457.
119. Andrews, N. A.; Jones, A. S.; Helliwell, T. R.; Kinsella, A. R. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br. J. Cancer 1997, 75, 1474-1480.
120. Yang, F.; Zeng, Q.; Yu, G.; Li, S.; Wang, C. Y. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal. 2006, 18, 679-687.
121. Kuphal, F.; Behrens, J. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Exp. Cell Res. 2006, 312, 457-467.
122. Hirvikoski, P.; Kumpulainen, E. J.; Virtaniemi, J. A.; Helin, H. J.; Rantala, I.; Johansson, R. T.; Juhola, M.; Kosma, V. M. Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. Int. J. Cancer 1998, 79, 546-550.
123. Rosen, K.; Rak, J.; Leung, T.; Dean, N. M.; Kerbel, R. S.; Filmus, J. Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol. 2000, 149, 447-456.
124. Tran, N. L.; Adams, D. G.; Vaillancourt, R. R.; Heimark, R. L. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J. Biol. Chem. 2002, 277, 32905-32914.
125. Frisch, S. M.; Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124, 619-626.
126. Frisch, S. M.; Screaton, R. A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13, 555-562.
127. Kruamer, R. H. S. X.; Zhou, H. Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev. 2005, 24, 35-45.
128. Grossmann, J. Molecular mechanisms of "detachment-induced apoptosis - Anoikis". Apoptosis 2002, 7, 247-260.
129. Yu, X. M. S.; Mekada, E. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. J. Cell Sci. 2000, 113, 2139-2147.
130. Morales, J.; Homey, B.; Vicari, A. P.; Hudak, S.; Oldham, E.; Hedrick, J.; Orozco, R.; Copeland, N. G.; Jenkins, N. A.; McEvoy, L. M.; Zlotnik, A. CTACK, a skin-associated chemokine that preferentially attracts skin- homing memory T cells. Proc. Natl. Acad. Sci. USA 1999, 96, 14470-14475.
131. Muller, A.; Sonkoly, E.; Eulert, C.; Gerber, P. A.; Kubitza, R.; Schirlau, K.; Franken-Kunkel, P.; Poremba, C.; Snyderman, C.; Klotz, L. O.; Ruzicka, T.; Bier, H.; Zlotnik, A.; Whiteside, T. L.; Homey, B.; Hoffmann, T. K. Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy. Int. J. Cancer 2006, 118, 2147-2157.
132. Peled, A.; Petit, I.; Kollet, O.; Magid, M.; Ponomaryov, T.; Byk, T.; Nagler, A.; Ben-Hur, H.; Many, A.; Shultz, L.; Lider, O.; Alon, R.; Zipori, D.; Lapidot, T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283, 845-848.
133. Forster, R.; Schubel, A.; Breitfeld, D.; Kremmer, E.; Renner-Muller, I.; Wolf, E.; Lipp, M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99, 23-33.
134. Feng, Y.; Broder, C. C.; Kennedy, P. E.; Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272, 872-877.
135. Davis, C. B.; Dikic, I.; Unutmaz, D.; Hill, C. M.; Arthos, J.; Siani, M. A.; Thompson, D. A.; Schlessinger, J.; Littman, D. R. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 1997, 186, 1793-1798.
136. Zaitseva, M.; Blauvelt, A.; Lee, S.; Lapham, C. K.; Klaus-Kovtun, V.; Mostowski, H.; Manischewitz, J.; Golding, H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 1997, 3, 1369-1375.
137. Sanchez, X.; Cousins-Hodges, B.; Aguilar, T.; Gosselink, P.; Lu, Z.; Navarro, J. Activation of HIV-1 coreceptor (CXCR4) mediates myelosuppression. J. Biol. Chem. 1997, 272, 27529-27531.
138. Broxmeyer, H. E.; Youn, B. S.; Kim, C.; Hangoc, G.; Cooper, S.; Mantel, C. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G alpha i protein. Ann. N.Y. Acad. Sci. 2001, 938, 117-127.
139. Guleng, B.; Tateishi, K.; Ohta, M.; Kanai, F.; Jazag, A.; Ijichi, H.; Tanaka, Y.; Washida, M.; Morikane, K.; Fukushima, Y.; Yamori, T.; Tsuruo, T.; Kawabe, T.; Miyagishi, M.; Taira, K.; Sata, M.; Omata, M. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res. 2005, 65, 5864-5871.
140. Majka, M.; Janowska-Wieczorek, A.; Ratajczak, J.; Kowalska, M. A.; Vilaire, G.; Pan, Z. K.; Honczarenko, M.; Marquez, L. A.; Poncz, M.; Ratajczak, M. Z. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood 2000, 96, 4142-4151.
141. Majka, M.; Ratajczak, J.; Kowalska, M. A.; Ratajczak, M. Z. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur. J. Haematol. 2000, 64, 164-172.
142. Majka, M.; Ratajczak, J.; Lee, B.; Honczarenko, M.; Douglas, R.; Kowalska, M. A.; Silberstein, L.; Gewirtz, A. M.; Ratajczak, M. Z. The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro. Stem Cells 2000, 18, 128-138.
143. Kijowski, J.; Baj-Krzyworzeka, M.; Majka, M.; Reca, R.; Marquez, L. A.; Christofidou-Solomidou, M.; Janowska-Wieczorek, A.; Ratajczak, M. Z. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 2001, 19, 453-466.
144. Salvucci, O.; Yao, L.; Villalba, S.; Sajewicz, A.; Pittaluga, S.; Tosato, G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002, 99, 2703-2711.
145. Muller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M. E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S. N.; Barrera, J. L.; Mohar, A.; Verastegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410, 50-56.
146. Scotton, C. M. D.; Wilson J.; Raju, S.; Balkwill, F. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br. J. Cancer 2001, 85, 891-897.
147. Phillips, R. J.; Burdick, M. D.; Lutz, M.; Belperio, J. A.; Keane, M. P.; Strieter, R. M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 2003, 167, 1676-1686.
148. Taichman, R. S.; Cooper, C.; Keller, E. T.; Pienta, K. J.; Taichman, N. S.; McCauley, L. K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002, 62, 1832-1837.
149. Kijima, T.; Maulik, G.; Ma, P. C.; Tibaldi, E. V.; Turner, R. E.; Rollins, B.; Sattler, M.; Johnson, B. E.; Salgia, R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002, 62, 6304-6311.
150. Koshiba, T.; Hosotani, R.; Miyamoto, Y.; Ida, J.; Tsuji, S.; Nakajima, S.; Kawaguchi, M.; Kobayashi, H.; Doi, R.; Hori, T.; Fujii, N.; Imamura, M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 2000, 6, 3530-3535.
151. Katayama, A.; Ogino, T.; Bandoh, N.; Nonaka, S.; Harabuchi, Y. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Clin. Cancer Res. 2005, 11, 2937-2946.
152. Uchida, D.; Begum, N. M.; Almofti, A.; Nakashiro, K.; Kawamata, H.; Tateishi, Y.; Hamakawa, H.; Yoshida, H.; Sato, M. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp. Cell Res. 2003, 290, 289-302.